Portfolio

Exited through a Financial Secondary to Param Capital.

Exited through an IPO in India. Currently listed on NSE and BSE.

Exited through a Financial Secondary to Parkway capital and Northcreek in the US.

Exited in a Strategic sale to Affle.

Exited through a Financial Secondary to ADM Capital.

Exited through a Financial Secondary.

Acquired by Laurus Labs, an India listed Pharma Major

Facebook's first acquisition in India

Acquired by Fosun group.

Exited through a structured deal with Avendus.

Acquired by Genpact.

Acquired by Billdesk.

Exited to family office.

Exited with 13.5x return on investment.

Exited with 35x return on Investment.

Exited through a financial secondary delivering 9.5x returns

Exited to Japan listed Istlye Inc. with 50x return.

Acquired by Orange Health Solutions delivering 9x return

Exited through India (BSE) Listing.

Acquired by NASDAQ Listed Cancer Genetics and JASDAQ listed Reprocell.

Exited to a strategic.

Exited through Swiss Stock Exchange (SWX) listing.

Exited through NASDAQ listing.

Exited to Financial Investors.

Acquired by 1mg.

Exited to Next Education India.

Acquired by Enel Group

Exited through BSE Listing.

Exited through secondary sale

Exited through secondary sale